We use cookies to help provide you with the best possible online experience.
By using this site, you agree that we may store and access cookies on your device. Cookie policy.
Cookie settings.
Functional Cookies
Functional Cookies are enabled by default at all times so that we can save your preferences for cookie settings and ensure site works and delivers best experience.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
APRIL Trial
Millions of people in the UK have been infected with COVID-19.
As many as 1 in 5 people infected with COVID-19 continue to experience symptoms such as fatigue, brain fog, and muscle pain, for more than 12 weeks following their initial infection, a condition called Long COVID. This trial is trying to find out whether the Ayurvedic Indian herbal medicine Ashwaganda can promote recovery.
Why are we doing this study?
Currently, there is no established treatment for Long COVID. Researchers at the London School of Hygiene and Tropical Medicine are conducting a clinical trial to assess whether Ashwagandha, a traditional Indian herbal medicine, can promote recovery from Long COVID.
Who can take part?
- Those aged 18 or over who have been diagnosed with Long COVID and are still experiencing symptoms that affect their day-to-day lives and live in the UK